Table of Contents

Symposium on biosynthetic human insulin.

• J S Skyler,
• E F Pfeiffer,
• S Raptis,
• and G C Viberti

Biosynthetic human insulin: progress and prospects.

• P De Meyts,
• P Halban,
• and K D Hepp

In vitro studies on biosynthetic human insulin: an overview.

• R E Chance,
• E P Kroeff,
• J A Hoffmann,
• and B H Frank

Chemical, physical, and biologic properties of biosynthetic human insulin.

• S Raptis,
• C Karaiskos,
• F Enzmann,
• D Hatzidakis,
• C Zoupas,
• A Souvatzoglou,
• E Diamantopoulos,
• and S Moulopoulos

Biologic activities of biosynthetic human insulin in healthy volunteers and insulin-dependent diabetic patients monitored by the artificial endocrine pancreas.

• M Massi-Benedetti,
• J M Burrin,
• B Capaldo,
• and K G Alberti

A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects.

• P Bottermann,
• H Gyaram,
• K Wahl,
• R Ermler,
• and A Lebender

Pharmacokinetics of biosynthetic human insulin and characteristics of its effect.

• K Federlin,
• H Laube,
• and H G Velcovsky

Biologic and immunologic in vivo and in vitro studies with biosynthetic human insulin.

• G C Viberti,
• J C Pickup,
• H Keen,
• R W Bilous,
• M Mattock,
• R J Jarrett,
• A Glynne,
• and R Rogers

Biosynthetic human insulin: effect in healthy men on plasma glucose and non-esterified fatty acids in comparison with highly purified pork insulin.

• K Weinges,
• M Ehrhardt,
• and F Enzmann

Comparison of biosynthetic human insulin and pork insulin in the Gerritzen test.

• J A Galloway,
• C T Spradlin,
• M A Root,
• and S E Fineberg

The plasma glucose response of normal fasting subjects to neutral regular and NPH biosynthetic human and purified pork insulins.

• J Beyer,
• T Weber,
• G Schulz,
• W Hassinger,
• A Westerburg,
• and U Cordes

Comparison of biosynthetic human insulin and pork insulin during rest, food ingestion, and physical work in insulin-dependent diabetic subjects using a glucose controlled insulin infusion system.

• M Klier,
• W Kerner,
• A A Torres,
• and E F Pfeiffer

Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system.

• G Schernthaner,
• H Ludwig,
• R Jarisch,
• and H Bruneder

Immediate-type allergy against insulin itself: clinical and immunologic studies on a diabetic patient with insulin intolerance.

• W Beischer,
• V Maier,
• E M Jonatha,
• D Hartweg,
• and G Kratzsch

Immunologic properties of biosynthetic human insulin in vitro.

• W K Waldhäusl,
• G Kastner,
• M Komjati,
• and P Bratusch-Marrain

Studies on the biologic actions of biosynthetic human insulin in vitro and in diabetic man.

• L M Keefer,
• M A Piron,
• and P De Meyts

Receptor binding properties and biologic activity in vitro of biosynthetic human insulin.

• W Bachmann,
• C Sieger,
• F Lacher,
• and N Lotz

Binding of biosynthetic human insulin to erythrocytes of normal and insulin-dependent diabetic subjects: comparison with pork and human pancreatic insulin.

• J L Carpentier,
• P A Halban,
• A E Renold,
• and L Orci

Internalization of 125I-insulin by IM-9 cultured human lymphocytes: a comparison between A14-monoiodo-pork and biosynthetic human insulin.

• M Fehlmann,
• Y Le Marchand-Brustel,
• J Dolais-Kitabgi,
• O Morin,
• and P Freychet

Biologic activity and receptor binding properties of biosynthetic human insulin in isolated rat hepatocytes and mouse soleus muscle in vitro.

• R D Fussgaenger,
• H H Ditschuneit,
• H Martini,
• H Wiebauer-De Lenardis,
• H Etzrodt,
• C Thun,
• H Ditschuneit,
• E F Pfeiffer,
• and F Enzmann

Potency of biosynthetic human insulin determined in vitro.

• S Gammeltoft

Receptor binding of biosynthetic human insulin on isolated pig hepatocytes.

• P A Halban,
• M Berger,
• A Gjinovci,
• and A E Renold

Biologic activity and pharmacokinetics of biosynthetic human insulin in the rat.

• J M Olefsky

Insulin binding, biologic activity, and metabolism of biosynthetic human insulin.

• K G Petersen,
• K Schlüter,
• S Steinhilber,
• and L Kerp

Binding of biosynthetic human insulin to human antibodies and receptors.

• O Sonne,
• J E Foley,
• and J Gliemann

The biologic potency and binding affinity of biosynthetic human insulin in isolated rat adipocytes.

• E J Verspohl and
• H P Ammon

Binding of insulin to rat pancreatic islets: comparison between pancreatic human insulin and biosynthetic human insulin.

• T Wieringa,
• J P van Putten,
• M Van Dijk-Besling,
• and H M Krans

Receptor binding and effect of biosynthetic human insulin on 2-deoxyglucose transport.

• J Zapf and
• E R Froesch

Comparison of pancreatic human and biosynthetic human insulin with respect to their action on adipocytes and chick embryo fibroblasts.

• J A Galloway and
• J H Marsden

Clinical trials with biosynthetic human insulin.

• J E Gerich

An appraisal of the role of biosynthetic human insulin in the future treatment of diabetes mellitus.

• D J Chisholm,
• E W Kraegen,
• and G S Zelenka

Programming of insulin delivery with meals during subcutaneous insulin infusion.

• J Barbosa,
• L Menth,
• J Eaton,
• D Sutherland,
• E F Freier,
• and J Najarian

Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.

• W K Davis,
• A L Hull,
• and M L Boutaugh

Factors affecting the educational diagnosis of diabetic patients.

• N J Goldberg,
• T D Wingert,
• S R Levin,
• S E Wilson,
• and J F Viljoen

Insulin therapy in the diabetic surgical patient: metabolic and hormone response to low dose insulin infusion.

• R S Doody and
• N P Grose

The family medical history: assessing patient understanding of diabetes mellitus.

• M A Emanuele,
• B J Buchanan,
• and C Abraira

Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease.

• E A Ward,
• D A Lang,
• M R Phillips,
• and R C Turner

Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.

• M C Riddle

Relief of gastrointestinal symptoms by correcting insulin excess.

• R P Eaton,
• R Galagan,
• E Kaufman,
• R C Allen,
• L Russell,
• and F Miller

Receptor depletion in diabetes mellitus: correction with therapy.

• F Q Nuttall and
• M C Gannon

Sucrose and disease.

• J S Skyler,
• D L Skyler,
• D E Seigler,
• and M J O'Sullivan

Algorithms for adjustment of insulin dosage by patients who monitor blood glucose.

• D S Schade,
• R P Eaton,
• G A Carlson,
• R E Bair,
• J I Gaona, Jr,
• J T Love,
• R S Urenda,
• and W J Spencer

Future therapy of the insulin-dependent diabetic patient--the implantable insulin delivery system.

• E B Marliss,
• D Caron,
• A M Albisser,
• and B Zinman

Present and future expectations regarding insulin infusion systems.

• J S Skyler and
• F A Neelson

An algebra for adiposity?

• M W Linn

How mystic is a statistic?

• R K Campbell and
• P D Hansten

Metabolism of chlorpropamide.

• C M Kesson and
• G R Bailie

Do diabetic patients inject accurate doses of insulin?

• M F Kossover and
• J J Kossover

Meters or strips?

• C R Shuman and
• I L Spratt

Office guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance.